HK1002831A1 - Microballs including a pharmaceutically active ingredient and a polymer - Google Patents

Microballs including a pharmaceutically active ingredient and a polymer Download PDF

Info

Publication number
HK1002831A1
HK1002831A1 HK98101938A HK98101938A HK1002831A1 HK 1002831 A1 HK1002831 A1 HK 1002831A1 HK 98101938 A HK98101938 A HK 98101938A HK 98101938 A HK98101938 A HK 98101938A HK 1002831 A1 HK1002831 A1 HK 1002831A1
Authority
HK
Hong Kong
Prior art keywords
microballs
active ingredient
polymer
pharmaceutically active
external surface
Prior art date
Application number
HK98101938A
Other languages
English (en)
Chinese (zh)
Other versions
HK1002831B (en
Inventor
Ruiz Jean-Marc
Original Assignee
Ipsen Pharma S.A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma S.A.S. filed Critical Ipsen Pharma S.A.S.
Publication of HK1002831A1 publication Critical patent/HK1002831A1/xx
Publication of HK1002831B publication Critical patent/HK1002831B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
HK98101938.6A 1993-05-15 1998-03-10 Microballs including a pharmaceutically active ingredient and a polymer HK1002831B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310030A GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same
GB9310030 1993-05-15

Publications (2)

Publication Number Publication Date
HK1002831A1 true HK1002831A1 (en) 1998-09-18
HK1002831B HK1002831B (en) 1998-09-18

Family

ID=

Also Published As

Publication number Publication date
GB2277915A (en) 1994-11-16
FI112915B (fi) 2004-02-13
AU6308494A (en) 1994-11-17
ITMI940931A0 (it) 1994-05-11
DE4416812C2 (de) 2003-02-06
SE519004C2 (sv) 2002-12-17
GR1002034B (en) 1995-10-31
JPH072652A (ja) 1995-01-06
RU2125869C1 (ru) 1999-02-10
CN1050534C (zh) 2000-03-22
FR2705232B1 (fr) 1995-08-25
SE9401557D0 (sv) 1994-05-05
CA2123481A1 (en) 1994-11-16
AT406017B (de) 2000-01-25
PT101518A (pt) 1995-03-01
CN1104557A (zh) 1995-07-05
SG46631A1 (en) 1998-02-20
BR9401968A (pt) 1994-12-13
DZ1779A1 (fr) 2002-02-17
GB9409565D0 (en) 1994-07-06
ATA98794A (de) 1999-06-15
CA2123481C (en) 2005-01-11
PL175780B1 (pl) 1999-02-26
HUT67599A (en) 1995-04-28
FI942222A0 (fi) 1994-05-13
NO941810D0 (no) 1994-05-13
ITMI940931A1 (it) 1995-11-11
FI942222L (fi) 1994-11-16
ES2097083A1 (es) 1997-03-16
KR100341261B1 (ko) 2002-09-27
DE4416812A1 (de) 1994-11-17
NZ260520A (en) 1994-12-22
DK54994A (da) 1994-11-16
BE1008323A3 (fr) 1996-04-02
SE9401557L (sv) 1994-11-16
TNSN94046A1 (fr) 1995-04-25
LU88482A1 (fr) 1994-12-01
IE940392A1 (en) 1994-11-16
GB9310030D0 (en) 1993-06-30
AU685094B2 (en) 1998-01-15
OA09939A (fr) 1994-11-15
DK171454B1 (da) 1996-11-04
NO941810L (no) 1994-11-16
GB2277915B (en) 1997-10-29
CH688572A5 (fr) 1997-11-28
FR2705232A1 (fr) 1994-11-25
ZA943316B (en) 1995-01-16
JP3139913B2 (ja) 2001-03-05
IN182330B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1999-03-20
IT1269508B (it) 1997-04-01
ES2097083B1 (es) 1997-12-01
HU220617B1 (hu) 2002-03-28
NL9400795A (nl) 1994-12-01
NO307403B1 (no) 2000-04-03
HU9401412D0 (en) 1994-08-29
PT101518B (pt) 2000-12-29
MA23194A1 (fr) 1994-12-31

Similar Documents

Publication Publication Date Title
CA2270861A1 (en) Acetabular cup assembly with selected bearing
CA2304568A1 (en) Olanzapine pamoate formulations
CA2123481A1 (en) Process for the preparation of microballs and microballs thus obtained
CA2101245A1 (en) Dosage forms comprising polymers comprising different molecular weights
CA2105887A1 (en) Bioerodible device for administering active ingredients
WO2002049620A3 (en) Induced phase transition method for the production of microparticles containing hydrophobic active agents
EP1690530A3 (en) Sustained release pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
CA2257976A1 (en) Compositions and methods for coating medical devices
AU1575888A (en) Joint prosthesis
CA2348016A1 (en) Controlled release liquid delivery compositions with low initial drug burst
CA2299511A1 (en) A pharmaceutical composition having two coating layers
CA2195094A1 (en) Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
BR9306848A (pt) Anel polimérico dividido para introdução no estroma
EP0643963A3 (en) Biologically erodible device for the administration of active substances.
CA2254833A1 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
EP0269745A4 (en) BONE IMPLANT.
EP0815808A3 (en) Connector plug for multicomponent orthopedic implant
CA2151883A1 (en) Synthetic tropoelastin
CA2349633A1 (en) A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state
HUT63580A (en) Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
CA2000763A1 (en) Dispersable formulation
EP0358150A3 (en) Use of 5-(4-chlorophenyl)-2,4-dimethyl-3h-1,2,4-triazole-3-thione for preparing drugs for the treatment of thrombocytosis
CA2253130A1 (en) A medicament for treating obesity and improving lipid metabolism
CA2255052A1 (en) Sustained release preparation of prostaglandin i derivatives
WO2001032230A3 (en) A polymer micelle as monolayer or layer-laminated surface

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100513